glp 1 semaglutide and tirzepatide Retatrutide vs vs Compounded Tirzepatide Program: Results, Timeline

If you're considering Trulicity or any other GLP-1 agonist for weight loss, it's crucial to consult with your healthcare provider

Cardiovascular and Endothelial Benefits GLP-1 RAs have demonstrated robust cardiovascular protection in multiple large-scale trials, including LEADER, REWIND, and SUSTAIN-6, showing reduced rates of major adverse cardiac events independent of weight loss

Extended protocols beyond typical 8-12 week durations appear safe based on available evidence

They interact with other drugs, and certain people should not use them due to health risks

Address Dehydration-Induced Dryness Semaglutide may reduce appetite, and some individuals also drink less fluid as eating patterns change

For this study, Dr